Update #2
In support of
Lorrie's Journey
View Support Registry
Lorrie's Journey
Hello to all and hoping this finds you well.
Updating you on this past week and yesterday, Tuesday, 4/8/2025.
Last week I started 2 new drugs, Ivermectin and Mebendazole. Ivermectin is continuing to be studied and currently being used showing promising effects against various cancers.
Yesterday I had a zoom call with Dr. Whiteside who opened our time together in meaningful prayer. I found that to be refreshing and comforting.
Dr. Whiteside is a scientist with a background and focus in nanotechnology. He has had promising results in the field of peptide therapies where he can personalize the therapy uniquely to the individual and their type of cancer.
Peptides are short chain amino acids where proteins are long chain amino acids.
Peptides act as a Trojan horse to deliver nano particles into the cancer cells enhancing the efficacy of the holistic cytotoxic agent(s) being delivered to the cancer cell.
Dr. Whiteside recently gained approval from the FDA in starting a trial study. I may have an opportunity in the future to be part of this trial study.
Thank you again for your support and interest in following my journey.
Until my next update, may the Lord bless you and keep you.
Ever grateful! Lorrie
Updating you on this past week and yesterday, Tuesday, 4/8/2025.
Last week I started 2 new drugs, Ivermectin and Mebendazole. Ivermectin is continuing to be studied and currently being used showing promising effects against various cancers.
Yesterday I had a zoom call with Dr. Whiteside who opened our time together in meaningful prayer. I found that to be refreshing and comforting.
Dr. Whiteside is a scientist with a background and focus in nanotechnology. He has had promising results in the field of peptide therapies where he can personalize the therapy uniquely to the individual and their type of cancer.
Peptides are short chain amino acids where proteins are long chain amino acids.
Peptides act as a Trojan horse to deliver nano particles into the cancer cells enhancing the efficacy of the holistic cytotoxic agent(s) being delivered to the cancer cell.
Dr. Whiteside recently gained approval from the FDA in starting a trial study. I may have an opportunity in the future to be part of this trial study.
Thank you again for your support and interest in following my journey.
Until my next update, may the Lord bless you and keep you.
Ever grateful! Lorrie
Comments
Ann Marie Killough
Pam Glover